Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 08, 2026 08:45 ET | Source: Biofrontera Inc.

Biofrontera Inc. Announces Data Base Locks for Two Clinical Studies Supporting Key Data and Regulatory Milestones

Database locks for studies on actinic keratosis (AK) and acne vulgaris achieved on January 5, 2026Data generated will support key regulatory milestones for Ameluz PDT in both indicationsAK and acne...
January 08, 2026 08:45 ET | Source: Polyrizon Ltd.

Polyrizon Completes Branding Process for PL-14 Allergy Blocker with Brand Name NASARIX™

As part of the branding process, Polyrizon conducted comprehensive trademark screening across the U.S. and European markets Raanana, Israel, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd....
January 08, 2026 08:32 ET | Source: OwlTing Group

OBOOK Holdings Inc. (OWLS) to Adopt x402 Standard to Unlock AI Agent Revenue for Global Merchants

OBOOK Holdings Inc. (NASDAQ: OWLS) aims to integrate with the x402 ecosystem, an open standard introduced by Coinbase, for AI agents payments.
January 08, 2026 08:32 ET | Source: VivoPower International PLC

VivoPower Appoints Rachel Pether, Sovereign Wealth Fund Expert, to Global Advisory Council

Appointment further strengthens VivoPower’s footprint across the Middle East, a priority growth region for the Company’s Sovereign AI digital infrastructure and electric mobility platforms Based in...
January 08, 2026 08:30 ET | Source: Leslie’s Inc.

Leslie’s, Inc. Appoints John Hartmann to Board of Directors

PHOENIX, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Leslie's, Inc. ("Leslie's" or the “Company”; NASDAQ: LESL), the largest and most trusted direct-to-customer brand in the U.S. pool and spa care industry...
January 08, 2026 08:30 ET | Source: RenovoRx, Inc.

RenovoRx To Announce Promising New Clinical Data Using its TAMP™ Therapy Platform in an Abstract to be Presented at ASCO GI 2026

New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx’s TAMP Therapy Platform as a Targeted Drug-Delivery Approach Data Shows a...
January 08, 2026 08:30 ET | Source: Alliance Entertainment

Alliance Entertainment Appoints Jeffrey Smith as Senior Vice President of Sales and Marketing for Alliance Authentic™

PLANTATION, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Alliance Entertainment Holding Corporation (NASDAQ: AENT), the world’s largest distributor of vinyl records and a leading curator of physical...
January 08, 2026 08:30 ET | Source: Ardelyx, Inc.

Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook

Company achieved significant commercial progress in 2025, generating approximately $378 million in product revenue1 IBSRELA achieved $274 million in revenue in 2025, representing 73% growth vs....
January 08, 2026 08:30 ET | Source: NewtekOne, Inc.

NewtekOne, Inc. Posts Investor Day Presentation and Provides 2026 EPS Guidance Range of $2.15-$2.55

BOCA RATON, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (the “Company” or “NewtekOne”) (NASDAQ: NEWT) has posted to the Investor Relations section of its website (link) an investor...
January 08, 2026 08:30 ET | Source: Allogene Therapeutics, Inc.

Allogene Therapeutics Positions 2026 as a Program-Defining Year for Scalable, Real-World Allogeneic CAR T

1H 2026 Catalyst Stack Anticipated to Validate Scalable, Off-the-Shelf CAR T in Oncology and Autoimmune Disease Interim Futility Analysis of MRD Clearance from the Pivotal Phase 2 ALPHA3 Trial with...